• Explore /
  • Poster
  • / Therapeutic drug monitoring of 5-fluorouracil (5-FU) in the treatment of patients with colorectal cancer (CRC).

Therapeutic drug monitoring of 5-fluorouracil (5-FU) in the treatment of patients with colorectal cancer (CRC).

Abstract Poster

Authors

Gaurav Goel

Gaurav Goel

University of Pittsburgh Cancer Institute, Pittsburgh, PA

Gaurav Goel , Rajesh Sehgal , Dennis James Meisner , Min Sun , Gurleen Pasricha , Edward Chu , James J. Lee

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Translational Research

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 563)

DOI

10.1200/jco.2015.33.3_suppl.563

Abstract #

563

Poster Bd #

B7

Abstract Disclosures

Similar Posters

First Author: Gabriel A. Brooks

First Author: Sebastian Stintzing

Poster

2023 ASCO Gastrointestinal Cancers Symposium

A meta-analysis of bevacizumab’s cardiovascular risks in patients treated for colorectal cancer.

A meta-analysis of bevacizumab’s cardiovascular risks in patients treated for colorectal cancer.

First Author: Akshit Chitkara

First Author: Meinolf Karthaus